Financial News

ObsEva Files half Year 2023 Financial Statements

ObsEva Files half Year 2023 Financial Statements

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange

Geneva, SwitzerlandSeptember 27, 2023ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today published its Half Year 2023 Financial Statements. The Half Year 2023 Financial Statements may be found on the financial section of the Company’s website, here or directly via the link here.

About ObsEva

ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program focused on improving in vitro fertilization success rates. ObsEva is listed on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

For further information, please contact:

For general information:

contact@obseva.ch

For investors information:

IR@obseva.ch

###




Attachment


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback